{
    "name": "Progabide",
    "smiles": "O=C2C=CC(F)=C/C2=C(NCCCC(N)=O)c1ccc(Cl)cc1",
    "csid": 4514729,
    "link": "http://www.drugbank.ca/drugs/DB00837",
    "source": "DrugBank",
    "Reason": "1-ethylpiperazine-2,3-dione has a melting point around 106\u00b0C. The presence of two carbonyl groups generally increases the melting point due to the potential for hydrogen bonding and dipole-dipole interactions, which can raise it by approximately +10\u00b0C each. However, 1-ethyl substitution tends to lower the melting point compared to piperazine, as it creates a more asymmetric structure, reducing the crystal lattice stability, which might decrease the melting point by approximately -10\u00b0C. Summing up these changes: Piperazine base (+106\u00b0C), two carbonyl groups (+20\u00b0C), and one ethyl group (-10\u00b0C). Additionally, Progabide has a fused aromatic ring system, which can increase the melting point due to increased molecular rigidity and pi-stacking interactions; this effect is estimated to add about +25 \u00b0C for each additional fused ring. The molecular structure also includes a methoxy group, which can raise the melting point by approximately +5 \u00b0C due to additional molecular weight and the capacity for hydrogen bonding. Two ether linkages are present as well, and while they have less impact than methoxy groups, they still increase the melting point through slight contributions to molecular weight and possible weak dipole interactions, estimated at +2 \u00b0C for each ether.",
    "mpC": 134.0,
    "Prediction(integer)": 123.0,
    "Abs error": 6.0
}